000 | 01718 a2200457 4500 | ||
---|---|---|---|
005 | 20250518091855.0 | ||
264 | 0 | _c20210511 | |
008 | 202105s 0 0 eng d | ||
022 | _a1573-7365 | ||
024 | 7 |
_a10.1007/s11011-020-00551-0 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aKeshk, Walaa A | |
245 | 0 | 0 |
_aCurcumin attenuates cytoplasmic/endoplasmic reticulum stress, apoptosis and cholinergic dysfunction in diabetic rat hippocampus. _h[electronic resource] |
260 |
_bMetabolic brain disease _c04 2020 |
||
300 |
_a637-647 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 |
_aActivating Transcription Factor 4 _xgenetics |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aApoptosis _xdrug effects |
650 | 0 | 4 |
_aBlood Glucose _xmetabolism |
650 | 0 | 4 |
_aCholine O-Acetyltransferase _xgenetics |
650 | 0 | 4 |
_aCurcumin _xpharmacology |
650 | 0 | 4 |
_aDiabetes Mellitus, Experimental _xgenetics |
650 | 0 | 4 |
_aEndoplasmic Reticulum Stress _xdrug effects |
650 | 0 | 4 |
_aHSP70 Heat-Shock Proteins _xmetabolism |
650 | 0 | 4 |
_aHeat-Shock Proteins _xgenetics |
650 | 0 | 4 |
_aHippocampus _xdrug effects |
650 | 0 | 4 |
_aInterferon-gamma _xmetabolism |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aProtective Agents _xpharmacology |
650 | 0 | 4 |
_aProto-Oncogene Proteins c-bcl-2 _xgenetics |
650 | 0 | 4 | _aRats |
650 | 0 | 4 | _aRats, Wistar |
650 | 0 | 4 |
_aTranscription Factor CHOP _xmetabolism |
650 | 0 | 4 |
_abcl-2-Associated X Protein _xmetabolism |
700 | 1 | _aElseady, Walaa S | |
700 | 1 | _aSarhan, Naglaa I | |
700 | 1 | _aZineldeen, Doaa H | |
773 | 0 |
_tMetabolic brain disease _gvol. 35 _gno. 4 _gp. 637-647 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1007/s11011-020-00551-0 _zAvailable from publisher's website |
999 |
_c30742705 _d30742705 |